⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19088933 | 0.88 | — | — | |
| SCHEMBL2915548 | 0.80 | — | — | |
| SCHEMBL61448 | 0.76 | — | — | |
| Iodide SCHEMBL9257890 | 0.72 | — | — | |
| SCHEMBL121244 | 0.68 | — | — | |
| SCHEMBL346882 | 0.63 | — | — | |
| Aziridine SCHEMBL6424974 | 0.63 | — | — | |
| SCHEMBL8759377 | 0.63 | — | — | |
| SCHEMBL1652731 | 0.57 | — | — | |
| Aziridine SCHEMBL16878816 | 0.51 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 72 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11897796-B2 | Compositions of heterocyclic compounds and uses as sulfidogenesis inhibitors | CHAMPIONX USA INC. (US) | 2024-02-13 | — | — | US | claimed |
| EP-4093836-A1 | COMPOSITIONS OF HETEROCYCLIC COMPOUNDS AND USES AS SULFIDOGENESIS INHIBITORS | ChampionX USA Inc. (US) | 2022-11-30 | — | — | EP | claimed |
| US-20210238068-A1 | COMPOSITIONS OF HETEROCYCLIC COMPOUNDS AND USES AS SULFIDOGENESIS INHIBITORS | QUARTZDYNE, INC. | 2021-08-05 | — | — | US | claimed |
| WO-2021151083-A1 | COMPOSITIONS OF HETEROCYCLIC COMPOUNDS AND USES AS SULFIDOGENESIS INHIBITORS | CHAMPIONX USA INC. (US) | 2021-07-29 | — | — | WO | claimed |
| JP-4676960-B2 | — | — | 2011-04-27 | — | — | JP | claimed |
| US-7196103-B2 | Indole derivatives as factor Xa inhibitors | SANOFI-AVENTIS DEUTSCHLAND GMBH (DE) | 2007-03-27 | — | — | US | claimed |
| JP-2006528940-A | — | — | 2006-12-28 | — | — | JP | claimed |
| EP-1633746-A1 | NEW INDOLE DERIVATIVES AS FACTOR XA INHIBITORS | Sanofi-Aventis Deutschland GmbH (DE) | 2006-03-15 | — | — | EP | claimed |
| US-20050033049-A1 | Indole derivatives as factor Xa inhibitors | AVENTIS PHARMA DEUTSCHLAND GMBH (DE) | 2005-02-10 | — | — | US | claimed |
| WO-2004101554-A1 | NEW INDOLE DERIVATIVES AS FACTOR XA INHIBITORS | SANOFI-AVENTIS DEUTSCHLAND GMBH (DE) | 2004-11-25 | — | — | WO | claimed |
| EP-1479677-A1 | New indole derivatives as factor xa inhibitors | Aventis Pharma Deutschland GmbH (DE) | 2004-11-24 | — | — | EP | claimed |
| US-20250101291-A1 | INHIBITOR COMPOSITIONS COMPRISING SCALE AND CORROSION INHIBITORS | CHAMPIONX LLC (US) | 2025-03-27 | — | — | US | disclosed |
| WO-2025064760-A1 | INHIBITOR COMPOSITIONS COMPRISING SCALE AND CORROSION INHIBITORS | CHAMPIONX LLC (US) | 2025-03-27 | — | — | WO | disclosed |
| EP-4508159-A1 | SOLID PARAFFIN INHIBITOR AND CORROSION INHIBITOR COMPOSITIONS | ChampionX LLC (US) | 2025-02-19 | — | — | EP | disclosed |
| US-12195371-B2 | Antifouling compounds used for microbial fouling control | ECOLAB USA INC. (US) | 2025-01-14 | — | — | US | disclosed |
| US-7196103-B2 | Indole derivatives as factor Xa inhibitors | SANOFI-AVENTIS DEUTSCHLAND GMBH (DE) | 2007-03-27 | — | — | US | disclosed |
| EP-1633746-A1 | NEW INDOLE DERIVATIVES AS FACTOR XA INHIBITORS | Sanofi-Aventis Deutschland GmbH (DE) | 2006-03-15 | — | — | EP | disclosed |
| US-20050033049-A1 | Indole derivatives as factor Xa inhibitors | AVENTIS PHARMA DEUTSCHLAND GMBH (DE) | 2005-02-10 | — | — | US | disclosed |
| WO-2004101554-A1 | NEW INDOLE DERIVATIVES AS FACTOR XA INHIBITORS | SANOFI-AVENTIS DEUTSCHLAND GMBH (DE) | 2004-11-25 | — | — | WO | disclosed |
| EP-1479677-A1 | New indole derivatives as factor xa inhibitors | Aventis Pharma Deutschland GmbH (DE) | 2004-11-24 | — | — | EP | disclosed |